Cargando…
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
The Abbott ID Now COVID-19 assay is a point-of-care molecular diagnostic tool for the detection of SARS-CoV-2. We prospectively monitored implementation of the assay in a tertiary care hospital emergency department (ED) for the diagnosis of early symptomatic patients. A total of 269 paired nasophary...
Autores principales: | Deslandes, Vincent, Clark, Eric, Thiruganasambandamoorthy, Venkatesh, Desjardins, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626348/ https://www.ncbi.nlm.nih.gov/pubmed/34933188 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115609 |
Ejemplares similares
-
Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023) -
Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021) -
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022) -
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021) -
Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)